Pancreatic Cancer Research

ResearcherUniversity of KansasActive in the last 2 years

Shrikant Anant

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4193-3053; OpenAlex author ID A5035668092. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 13

  1. Role of STAT3 in pancreatic cancer. Last author DOI 10.37349/etat.2024.00202↗
  2. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer. Co-author DOI 10.3390/ijms24076336↗
  3. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04572-8↗
  4. Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Co-author DOI 10.1038/s41419-022-04615-0↗
  5. Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy. Co-author DOI 10.18053/jctres.07.202102.008↗
  6. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Last author DOI 10.1053/j.gastro.2019.11.279↗
  7. Super-enhancers: novel target for pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.26704↗
  8. Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer. Last author DOI 10.2174/0929867324666170127095832↗
  9. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.6560↗
  10. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.4871↗
  11. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Last author DOI 10.1158/1535-7163.mct-12-0102↗
  12. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Last author DOI 10.1158/1535-7163.mct-11-0399↗
  13. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0016958↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Prasad R. Dandawate · 6 shared papers, 2016–2023 · strength 0.65
  2. Dharmalingam Subramaniam · 8 shared papers, 2011–2020 · strength 0.47
  3. Michael Nathan VanSaun · 3 shared papers, 2022–2023 · strength 0.45
  4. Anup Kasi · 3 shared papers, 2020–2023 · strength 0.38
  5. Subhash Padhyé · 4 shared papers, 2015–2023 · strength 0.33
  6. Zachary Hamel · 1 shared paper, 2024 · strength 0.31
  7. Stefan H. Bossmann · 2 shared papers, 2021–2023 · strength 0.30
  8. Animesh Dhar · 5 shared papers, 2011–2020 · strength 0.30
  9. Sharon Manley · 2 shared papers, 2022 · strength 0.29
  10. Appolinaire A. Olou · 2 shared papers, 2022 · strength 0.29
  11. Bailey A. Bye · 2 shared papers, 2022 · strength 0.29
  12. Mariana T. Ruckert · 2 shared papers, 2022 · strength 0.29
  13. R. McKinnon Walsh · 2 shared papers, 2022 · strength 0.29
  14. Weijing Sun · 2 shared papers, 2020–2021 · strength 0.22
  15. Chandrayee Ghosh · 2 shared papers, 2019–2020 · strength 0.18
  16. Sangita Bhattacharyya · 1 shared paper, 2023 · strength 0.16
  17. Obdulia Covarrubias‐Zambrano · 1 shared paper, 2023 · strength 0.16
  18. Jessica Allen · 1 shared paper, 2021 · strength 0.14
  19. Domenico Coppola · 1 shared paper, 2020 · strength 0.08
  20. Mokenge Peter Malafa · 1 shared paper, 2020 · strength 0.08
  21. Sivapriya Ponnurangam · 2 shared papers, 2012–2016 · strength 0.08
  22. Danny R. Welch · 2 shared papers, 2011–2015 · strength 0.07
  23. Sitaram Harihar · 1 shared paper, 2015 · strength 0.04
  24. Parthasarathy Rangarajan · 1 shared paper, 2015 · strength 0.04
  25. Giridharan Periyasamy · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.